Home > Boards > Canadian > Biotechs >


RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 7/18/2016 10:26:40 AM - Followers: 2 - Board type: Free - Posts Today: 0

This Undiscovered Company has 6 Drugs on Market and 5 under review by Health Canada . The Game Changer for Pediapharm is Easyhaler which expected to approved before year end .Another reason to own the Stock is the upcoming US-Partnership for Naproxen which also expected before year end . This Stock is a Lifetime Opportunity .

Pediapharm (PDP)

MarketCap: C$ 22.2 Millionen
Cash: $5.5 Millionen

Price: $0.31

Nice Summary (Fact Sheet)

Pediapharm has submitted its reconsideration package to Health Canada regarding Easyhaler Budesonide. The Company’s objective remains to obtain a marketing approval by the end of 2015.

Furthermore, before the end of 2015, the Company intends to sign an agreement with a US commercial partner for the selling and marketing of its first product acquisition in the US; namely the Pediapharm Naproxen Suspension. Pediapharm believes that with this agreement, the Company will reach profitability more rapidly.
#5   Great News BioSpecialist 07/18/16 10:26:40 AM
#4   2 Approvals around the corner = 300-500% upside BioSpecialist 07/13/16 11:27:17 AM
#3   The Company is close to profitability and with BioSpecialist 11/14/15 03:56:42 AM
#2   PDP: 14M curr peak (not actual) sales + seventhwave 11/13/15 04:18:44 PM
#1   This Undiscovered Company has 6 Drugs on Market BioSpecialist 11/13/15 01:39:02 PM
Consent Preferences